56 hasil untuk "Kidd, Mark"
Menampilkan 1–20 · 0,30 detik · RSS
-
Artikel Jurnal Teks lengkap
The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are increasing in both incidence and prevalence. A delay in correct diagnosis is common for these lesions. This reflects the absence of specific blood biomarkers to detect NENs. Measurement of the neuroendocrine secretory peptide…
-
Artikel Jurnal Teks lengkap
Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors
BACKGROUND: Tumor transcriptomes contain information of critical value to understanding the different capacities of a cell at both a physiological and pathological level. In terms of clinical relevance, they provide information regarding the cellular “toolbox” e.g., pathways associated with…
-
Artikel Jurnal Teks lengkap
New Pharmacologic Therapies for Gastroenteropancreatic Neuroendocrine Tumors
Successful treatment of unresectable and metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) requires the thoughtful choice of systemic therapy as a component of a multidisciplinary therapeutic approach. The role of somatostatin analogs is established in symptom relief, but there is…
-
Artikel Jurnal Teks lengkap
Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), considered a heterogeneous neoplasia, exhibit ill-defined pathobiology and protean symptomatology and are ubiquitous in location. They are difficult to diagnose, challenging to manage, and outcome depends on cell type, secretory product…
-
Artikel Jurnal Teks lengkap
Blood transcript analysis and metastatic recurrent small bowel carcinoid management
BACKGROUND: Detection of neuroendocrine tumor (NET) disease progression is a key issue in determining management. Currently, assessment is by imaging (MRI/CT and Octreoscan®) and plasma Chromogranin A (CgA) measurement. CASE PRESENTATION: We report use of a NET-specific multigene PCR-derived blood…
-
Artikel Jurnal Teks lengkap
The NETest liquid biopsy identifies paragangliomas and pheochromocytomas with ~100% accuracy
Pheochromocytomas and paragangliomas (PHEOs/PGLs) represent diagnostically challenging and complex neuroendocrine tumors. Current biomarker tests for PHEOs/PGLs are technically complex or limited. We assessed the diagnostic utility of the NETest in patients with PHEOs/PGLs (n=81), including 10…
-
Artikel Jurnal Teks lengkap
ABO Blood Group, Helicobacter pylori Seropositivity, and Risk of Pancreatic Cancer: A Case–Control Study
Carriage of a non–O ABO blood group and colonization by Helicobacter pylori are thought to be risk factors for pancreatic cancer. We examined these associations in a population-based case–control study of 373 case patients and 690 control subjects frequency matched on sex and age. Control subjects…
-
Artikel Jurnal Teks lengkap
The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors
Bronchopulmonary (BP) neuroendocrine tumors (NETs) comprise a spectrum of tumors that develop from respiratory neuroendocrine cells and represent ~20% of all lung neoplasia and ~30% of all NETs. The only curative treatment is surgical resection. For well-differentiated forms (typical and atypical…
-
Artikel Jurnal Teks lengkap
Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis
The survival duration for pancreatic cancer is short. Given its low lifetime risk (1.5%), established factors for the disease have insufficient specificity to identify individuals at high risk of nonfamilial cancer, and prediagnostic signs and symptoms are vague and not limited to pancreatic…
-
Artikel Jurnal Teks lengkap
Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer
Background/Objectives: Early detection of prostate cancer (PCa) enables timely therapeutic intervention and improved clinical outcomes. Screening strategies are increasingly individualized and now incorporate multiparametric MRI findings, reported using the Prostate Imaging Reporting and Data…
-
Artikel Jurnal Teks lengkap
Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma
Abstract Background For Hepatocellular Carcinoma (HCC) treated with hepatectomy, the extent of the resection margin remains controversial and data available on its effect on early tumor recurrence are very few and contradictory. The purpose of this study was to compare the impact of the type of…
Juga tersedia di: PubMed Central
-
Artikel Jurnal Teks lengkap
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
A critical requirement in neuroendocrine tumor (NET) management is a blood biomarker test that is sensitive, specific and reproducible. We evaluated a PCR-based 51-transcript signature to detect tumors, compared it with chromogranin A (CgA) and examined the confounding effect of proton pump…
-
Artikel Jurnal Teks lengkap
PROSTest, a Multigene Liquid Biopsy Signature, Effectively Stratifies Patients With High PSA for Prostate Biopsy
BACKGROUND: Prostate‐specific antigen (PSA) remains the standard biomarker for prostate cancer (PCa) detection, but its limited specificity—particularly in the 3–10 ng/mL range—leads to overdiagnosis and unnecessary biopsies. Including multiparameteric MRI (mpMRI) helps to reduce the number of…
-
Artikel Jurnal Teks lengkap
Case-control Study of Aspirin Use and Risk of Pancreatic Cancer
BACKGROUND: Pancreas-cancer prognosis is dismal, with 5-year survival less than 5%. Significant relationships between aspirin use and decreased pancreas-cancer incidence and mortality have been shown in four of 13 studies. METHODS: To evaluate further a possible association between aspirin use and…
-
Artikel Jurnal Teks lengkap
Clinical Sensitivity and Specificity of the PROSTest in an American Cohort
INTRODUCTION: Prostate cancer (PCa) is the most commonly diagnosed cancer in men in the United States, following skin cancer, with an incidence rate of 112.7 per 100,000 men per year. The need for a reliable, non‐invasive diagnostic tool for early PCa detection (screening, biochemical residual…
-
Artikel Jurnal Teks lengkap
Utility of the PROSTest, a Novel Blood‐Based Molecular Assay, Versus PSA for Prostate Cancer Stratification and Detection of Disease
BACKGROUND: Prostate cancer (PCa) is the most common solid organ cancer in men and the fifth leading cause of cancer‐related deaths globally. PSA helps identify men at risk but has low specificity and has resulted in unnecessary biopsies. The PROSTest, a novel machine learning‐based 27‐gene mRNA…
-
Artikel Jurnal Teks lengkap
Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
INTRODUCTION: Chromogranin A is a neuroendocrine secretory product and its loss is a feature of malignant NEN de-differentiation. We hypothesized that chromogranin A fragments were differentially expressed during NEN metastasis and played a role in the regulation of NEN proliferation. METHODS…
-
Artikel Jurnal Teks lengkap
Q RT-PCR Detection of Chromogranin A
OBJECTIVE: Message and protein expression of CgA was examined to evaluate the sensitivity of a PCR-based approach in the detection of covert neuroendocrine (NE) tissue. SUMMARY BACKGROUND DATA: Immunohistochemical (IHC) measurement of chromogranin A (CgA) discriminates gastrointestinal (GI)…
-
Artikel Jurnal Teks lengkap
Minichromosome Maintenance Expression Defines Slow-Growing Gastroenteropancreatic Neuroendocrine Neoplasms()
BACKGROUND: Small intestinal neuroendocrine neoplasm (SI-NEN) proliferation is quantified by Ki67 measurements which capture G1-G2M phases of the cell cycle. G(0) and early G(1) phases, typical of slow-growing cells, can be detected by minichromosome maintenance protein (MCM) expression. We…